Your browser doesn't support javascript.
loading
Timelines to initiate a phase III trial across the globe: a sub-analysis of the APHINITY trial.
Franzoi, Maria Alice; Procter, Marion; Twelves, Chris; Ponde, Noam; Eiger, Daniel; Emond, Orianne; Clark, Emma; Parlier, Damien; Guillaume, Sébastien; Reaby, Linda; de Azambuja, Evandro; Bines, Jose.
Afiliação
  • Franzoi MA; Clinical Trials Support Unit, Jules Bordet Institute, Brussels, Belgium.
  • Procter M; 0000-0002-2470-6054.
  • Twelves C; Frontier Science Scotland Ltd, Kincraig, Kingussie, UK.
  • Ponde N; University of Leeds and Leeds Teaching Hospitals Trust, Leeds, UK.
  • Eiger D; AC Camargo Cancer Center, São Paulo, Brazil.
  • Emond O; F Hoffmann-La Roche Ltd, Basel, Switzerland.
  • Clark E; Roche Products Ltd, Welwyn Garden City, UK.
  • Parlier D; Roche Products Ltd, Welwyn Garden City, UK.
  • Guillaume S; Clinical Trials Support Unit, Jules Bordet Institute, Brussels, Belgium.
  • Reaby L; Clinical Trials Support Unit, Jules Bordet Institute, Brussels, Belgium.
  • de Azambuja E; Patient Representative, Newcastle, Australia.
  • Bines J; Clinical Trials Support Unit, Jules Bordet Institute, Brussels, Belgium.
Ecancermedicalscience ; 16: 1379, 2022.
Article em En | MEDLINE | ID: mdl-35702414
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Ecancermedicalscience Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Bélgica
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Ecancermedicalscience Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Bélgica